This report studies the global medical aesthetics market over the forecast period of 2016 to 2021. The market is expected to reach USD 13.29 Billion by 2021, at CAGR of 10.8% from 2016 to 2021.
The report “Medical Aesthetics Market by Product (Liposuction, Cellulite & Fat Reduction, Skin Tightening, Breast Implants, Botox, Dermal Fillers, Tattoo Removal, Thread Lift, Laser Hair Removal), End-User (Clinics & Medical Spas, Beauty Center) – Forecast to 2021”, that analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Browse 70 market data tables and 38 figures spread through 173 pages and in-depth TOC on “Medical Aesthetics Market by Product (Liposuction, Cellulite & Fat Reduction, Skin Tightening, Breast Implants, Botox, Dermal Fillers, Tattoo Removal, Thread Lift, Laser Hair Removal), End-User (Clinics & Medical Spas, Beauty Center) – Forecast to 2021”
A number of factors such as increasing inclination towards minimally invasive and non-invasive aesthetic procedures, rising demand for aesthetic treatments among the male population, and rapid growth in number of cosmetic procedures are driving the growth of the global medical aesthetics market. On the other hand, stringent safety regulations for aesthetic procedures and low focus of market players on development of medical aesthetic devices for dermatological conditions are restricting the growth of the global medical aesthetics market.The report covers nine major product types- energy-based devices, breast implants, facial aesthetics, tattoo removal devices, physician-dispensed cosmeceuticals and skin lighteners, thread lifting, physician-dispensed eyelash products, laser resurfacing devices, and laser hair removal devices. The energy-based devices segment is categorized into skin tightening and body shaping, liposuction devices, cellulite reduction devices and non-invasive fat reduction devices.
The breast implants segment is classified into silicone breast implants, saline breast implants, and cohesive semi-solid gel implants. The facial aesthetics segment is also categorized botulinum toxin (BOTOX), chemical peels, microdermabrasion, and dermal fillers.
Physician dispensed cosmeceuticals segment is expected to grow at the highest CAGR, mainly due to increasing aging population coupled with rising demand for anti-aging products to treat wrinkles and visible signs of aging,
Based on end-users, the global medical aesthetics market is categorized into two major segments, namely, clinics plus medical spas and beauty centers. The clinics and medical spas segment is expected to account for the larger share of the global medical aesthetic market in 2016 and grow at the higher CAGR during the forecast period.
This can be attributed to the growing number of clinics and medical spas and increasing number of skilled professionals to perform the aesthetic procedures.
In 2016, North America is expected to hold the largest share of the global medical aesthetic market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021.
A number of factors, such as growing number of aesthetic procedures, rising middle class with growing purchasing power , rising medical tourism, and increasing focus of global players is driving the growth of Asia-Pacific market.
Allergan, Inc. (Ireland), Cynosure, Inc. (U.S.), Lumenis Ltd. (Israel), Mentor Worldwide LLC (U.S PhotoMedex, Inc. (U.S.), Solta Medical, Inc. (U.S), Syneron Medical, Ltd. (Israel), Galderma S.A. (Switzerland), and ZELTIQ Aesthetics, Inc. (U.S.) are some of the main players in the global medical aesthetics market.